Name
COI
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for COI
Name
Alternate Names
1-OHP
1670 RBl Eloxatin
Eloxatin
L-OHP
Oxalatoplatin
Oxalatoplatinum
PR-54780
RP-54780
Transplatin
Abbreviations
None
Category
Chemotherapy
Subcategory
Platinum analog
NSC Number
266046
Primary Site
Histology
None
Remarks
A platinum-containing antineoplastic that is usually given in combiantion with 5-FU.
Coding
This drug should be coded
Name
Alternate Names
Camptosar
Camptosar Oral
Camptothecin-11
CPT 11
CPT-11
CPT11
U-101440E
Abbreviations
None
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
616348
Primary Site
Colorectal
head & neck
Non-small cell lung cancer (NSCLC)
pancreatic cancer
Small cell lung cancer (SCLC)
Histology
None
Remarks
Phase I (head & neck) Phase III SCLC pancreatic Topoisomerase I inhibitor. FDA approved use on colorectal cancer. Pharmacia.
Coding
This drug should be coded
Name
Alternate Names
Ro 091978
Ro-09-1978
Ro-091978
Xeloda
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
712807
Primary Site
Histology
None
Remarks
FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.
Coding
This drug should be coded